Match Document Document Title
5736353 Assay reagents  
The present invention relates to a peroxidase-containing reagent comprising a buffered aqueous solution of a peroxidase conjugate and a substrate for the peroxidase, in the absence of peroxide. The...
5736343 Detection of organic compounds through regulation of antibody-catalyzed reactions  
The present invention provides a method for determining the presence of a target organic molecule in a sample which comprises either (A): first, adding a substrate molecule to the sample, the...
5733764 Method for purification of an aqueous enzyme solution  
Particular enzymes are precipitated from a mixture of proteins by the simultaneous addition of a soluble aluminate and acid. The pH of the mixture is at least one pH unit from the isoelectric point...
5728560 Method of treating CD4+ T cell lymphopenia in immuno-compromised patients  
The present invention is directed to methods of treating CD4+ T cell lymphopenia in HIV-infected patients. The methods include administering an effective mount of adenosine deaminase or related...
5728804 Use of cyclodextrins for protein renaturation  
A method for renaturing a denatured protein is provided comprising contacting a solution or suspension of said denatured protein in a detergent-free liquid medium with an amount of a cyclodextrin...
5719115 Coated enzyme preparation for detergents and cleaning formulations  
Enzyme granules containing an enzyme, an inorganic or organic carrier material and a uniform outer pigment-containing coating layer on the granules, wherein the outer coating layer contains 30 to...
5710009 Receptor:release ligand (reland) complexes and release assays using said reland and methods and kits based thereon  
Assays using receptor:reland complexes capable of releasing the reland in the presence of an analyte are described, wherein the reland does not detectably compete with analyte for binding to the...
5710040 Stable enzymatic aqueous liquid composition for the production of leather  
An aqueous liquid composition containing one or more enzymatic active substances and at least 10 wt % to a maximum of (100-x) wt % molasses, wherein x is the fraction of enzymatic active substances...
5707844 Immunoassay reagents and methods for detecting brequinar and analogs  
The present invention is directed to immunoassay reagents including specific antibodies to quinoline carboxylic acids, such as brequinar; novel quinoline carboxylic acid haptens useful as standards...
5705153 Glycolipid enzyme-polymer conjugates  
Conjugates containing glucocerebrosidase and non-antigenic polymers such as polyethylene glycol are disclosed. The conjugates circulate for extended times and have prolonged activity in vivo when...
5705382 Method for preserving nitrile hydratase or nitrilase activity of microbial cells with inorganic salts  
Cells having enzyme activity, and the enzyme activity thereof, are preserved for a prolonged period of time, as a suspension of microbial cells or as a suspension of immobilized cells in particles,...
5691154 Enzyme linked immunoassay with stabilized polymer saccharide enzyme conjugates  
An improvement in enzyme linked immunoassays is disclosed wherein the enzyme is in the form of a water soluble polymer saccharide conjugate which is stable in hostile environments. The conjugate...
5686253 Method of stabilizing enzyme conjugates  
A method is disclosed for stabilizing a conjugate of an enzyme and a member of a specific binding pair (enzyme conjugate). The method comprises the step of combining the enzyme conjugate with an...
5681750 Process for preparing a C1-esterase inhibitor concentrate (C1-INH), and concentrate obtained, for therapeutic use  
Disclosed is a process for preparing a C1-esterase inhibitor concentrate, of human plasma origin, comprising 2 separations by chromatography on ion exchanger gels of tentacular type.
5681927 Metal-radionuclide-labeled proteins and glycoproteins for diagnosis and therapy  
Chelated radionuclide compositions are provided for conjugation to polypeptides and carbohydrates. The resulting conjugates may be used in diagnosis and therapy.
5679548 Methods for producing polypeptide metal binding sites and compositions thereof  
The present invention describes methods for producing metal binding sites on polypeptides, and particularly for producing metal binding sites within the CDR regions of immunoglobulin heavy or light...
5674726 Enzyme stabilization with poly-L-lysine  
An enzyme reaction stabilizer consisting of poly-L-lysine or its salt as an effective constituent, a method for using the enzyme reaction stabilizer, and an enzyme preservative consisting of...
5674833 Detergent compositions containing protease and novel inhibitors for use therein  
A detergent composition and additive comprising a protease and a reversible protease inhibitor of the peptide or protein type, wherein the ratio of the dissociation constant to the protease...
5672489 Catalytic antibodies hydrolyzing acylated carbohydrates in a regioselective and stereoselective manner  
A method of regio-and stereoselective hydrolysis to deprotect an acylated hydroxy group in acylated carbohydrates, which contributes to synthesis of complex oligosaccharides, is provided. The...
5660978 Stabilization of analytes  
A method for stabilizing analytes with antibodies and antibody fragments comprises dissolving the analyte in a liquid to form a solution, adding analyte-specific antibodies, fragments of such...
5661020 Low diol polyalkylene oxide biologically active proteinaceous substances  
Disclosed are pharmaceutical compositions containing low diol polyethylene glycol, covalently attached to superoxide and dismutase process of making the compositions. Also disclosed is a method of...
5658753 Catalytic antibody components  
Catalytic antibody components, methods for producing catalytic antibody components, methods for using catalytic antibody components, in particular, single chain and smaller components are...
5658752 Method of catalyzing chemical reactions  
A method for increasing the rate of chemical reactions involving the conversion of at least one reactant to at least one product involves contacting the reactant with an appropriate monoclonal...
5650333 Immunoassay method and kit using superaggregated complex  
Methods of assaying samples for the presence or quantity of an analyte involving immobilization of a gold sol, and optionally an enzyme capable of generating a reaction product, on a solid phase....
5648075 Iodine based germicidal composition  
The present invention relates generally to an enzymatically generated iodine microbiocide and more specifically to the use of such a microbiocide for the inactivation of pathogenic organisms that...
5641865 Interaction system comprising a surfactant-stabilized disperse aqueous phase containing an antibody or antibody fragment  
An interaction system, including an antibody or, antibody fragment having functional capability, which comprises a surfactant-stabilized microheterogeneous dispersion of aqueous phase in a...
5639633 Method for synthesizing peptides with saccharide linked enzyme polymer conjugates  
A method is disclosed for synthesizing peptides using water soluble enzyme polymer conjugates. The method comprises catalyzing the peptide synthesis with enzyme which has been covalently bonded to...
5639481 Method for the therapeutic treatment of a mammalian eye using an admixed composition containing free molecular iodine  
The present invention relates generally to an enzymatically generated iodine microbicide and more specifically to the use of such a microbiocide for the inactivation of pathogenic organisms that...
5637473 Liquid-phase immunodiagnostic assay  
Reagents for a liquid-phase immunodiagnostic assay (LIDA) method comprise a first enzyme; a second enzyme; a first agent which is capable of binding with an analyte to form a complex, the agent...
5637468 Salt stabilization of antibody-enzyme conjugates heat-dried into paper  
New and useful methods of producing stabilized enzyme antibody conjugates are disclosed which are particularly useful in forming multi-layer immunoassay test devices. In particular, the invention...
5637467 Heterogeneous assay using a pendulous drop  
As method of determining an analyte is described, where a medium suspected of containing an analyte is drawn into a capillary tube by capillary action, such that if the analyte is present, it...
5621002 Prodrugs for enzyme mediated activation  
Enzymatically clearable prodrugs with reduced Michaelis-Menten constant (Km) are described.
5618681 Polyaromatic hydrocarbon (PAH) immunoassay method, its components and a kit for use in performing the same  
An immunoassay method that integrates a sample processing component that enables the testing of a variety of environmental matrixes and the components for performing the method, wherein the...
5612306 Stable enzyme-containing aqueous laundry prespotting composition  
A stable, enzyme-containing aqueous laundry prespotting composition. The composition includes at least one detergent enzyme in an amount effective to reduce fabric stains; an enzyme stabilizing...
5612460 Active carbonates of polyalkylene oxides for modification of polypeptides  
Poly(ethylene glycol)-N-succinimide carbonate and its preparation are disclosed. Polyethylene glycol (PEG) is converted into its N-succinimide carbonate derivative. This form of the polymer reacts...
5610283 Opiate derivatives and protein and polypeptide opiate derivative conjugates and labels  
The present invention is directed to novel opiate derivatives which are synthesized for the covalent attachment to antigens (proteins or polypeptides) for the preparation of antibodies or receptors...
5605661 Methods of using liquid enzyme compositions containing mixed polyols  
Compositions containing a stable, liquid, ophthalmically acceptable enzyme and methods involving the combined use of these compositions with a polymeric antimicrobial agent are disclosed for the...
5603931 Method for delivering a bioactive molecule to a cellular target  
Hybrid reagents comprising a first portion having an affinity for a cellular target and a second portion having an affinity for a bioactive molecule are described, said hybrid reagents being...
5601994 Immunoassay with novel labeled drug hapten analogues  
The invention is directed to labeled drug hapten analogues comprising: (A) a label, of the type used in immunoassays, having an amine or sulfhydryl group; (B) a drug hapten nucleus selected...
5602015 Autoantibodies which enhance the rate of a chemical reaction  
Autoantibodies which enhance the rate of a chemical reaction of a substrate, processes for their preparation, their use and compositions thereof are disclosed. In particular, an autoantibody...
5599538 Autoantibodies which enhance the rate of a chemical reaction  
Autoantibodies which enhance the rate of a chemical reaction of a substrate, processes for their preparation, their use and compositions thereof are disclosed. In particular, an autoantibody...
5595732 Polyethylene-protein conjugates  
The present invention is a physiologically active, substantially non-immunogenic water soluble polyethylene glycol protein conjugate having the same utility as the protein which forms the...
5591828 Bispecific and oligospecific mono-and oligovalent receptors, the preparation and use thereof  
The invention relates to bispecific and oligospecific, mono- and oligovalent receptors which are prepared by gene manipulation by fusion of DNA coding for F(ab) fragments of antibodies of two or...
5589370 Process for encapsulating sensitive materials  
The present invention relates to an improved curing or hardening process for the continuous production of capsules containing a sensitive material. The process allows capsules to be formed...
5589169 Method and therapeutic compositions for the prevention of fibrin deposition or adhesions  
A method and pharmaceutical composition for the prevention of fibrin deposition or adhesion formation by topical application of a composition to a site of potential fibrin deposition or adhesion...
5580486 Liquid detergents containing an α-amino boronic acid  
Aqueous liquid detergent compositions are described which comprise a proteolytic enzyme wherein the proteolytic activity is reversibly inhibited by an α-amino boronic acid.
5578457 Immunoassays with novel labeled carbamazepine hapten analogues  
An immunoassay method and analytical elements for detecting carbamazepine drugs, for example, in body fluids, is described. The immunoassay method comprises: (A) contacting a liquid sample,...
5578500 Reagents and methods for the quantification of imipramine or desipramine in biological fluids  
Immunoassay methods and reagents for the specific quantification of imipramine or desipramine in a test sample are disclosed. The measurement of imipramine or desipramine is accomplished in a...
5576174 Catalytic antibody with primary amine cofactor  
Antibodies raised against the quaternary piperidinium haptens are shown to catalyze the aldol stereoselective addition of acetone to aldehydes using the primary benzylamine as a cofactor.
5571681 Chemical event selection by suicide substrate conjugates  
Molecules having covalent catalytic activity are identified by panning synthetic and semisynthetic combinatorial libraries on solid phase suicide substrates. In an alternative mode, mechanism-based...